Epicatechin is a promising novel inhibitor of SARS-CoV-2 entry by disrupting interactions between angiotensin-converting enzyme type 2 and the viral receptor binding domain: A computational/simulation study. - Al-Shuhaib MBS; Hashim HO; Al-Shuhaib JMB (Computers in biology and medicine, 2022)